M.‐H. Fievet
- Hepatology top 5%
- Hepatitis C virus research 2
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment 2
- Epidemiology top 10%
- Urinary Tract Infections Management 2
- Hepatitis B Virus Studies 2
-
- Legionella and Acanthamoeba research 1
-
- Antibiotic Resistance in Bacteria 4
-
- Antibiotics Pharmacokinetics and Efficacy 3
-
- Medical Device Sterilization and Disinfection 2
- Co-authors
- Carol BrosgartChristine KatlamaHamid NaminiVincent ThibaultVincent CálvezThierry PoynardPamela VigJohn Fry
- Journals
- The Lancet (1 paper)Journal of Clinical Microbiology (1 paper)Journal of Hepatology (1 paper)
- Partner nations
- FranceUnited States
In The Last Decade
M.‐H. Fievet
11 papers receiving 347 citations
Peers
Comparison fields: 5 of 61
- Hepatology 205
- Infectious Diseases 149
- Epidemiology 270
- Applied Microbiology and Biotechnology 9
- Endocrinology 19
Countries citing papers authored by M.‐H. Fievet
This map shows the geographic impact of M.‐H. Fievet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.‐H. Fievet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.‐H. Fievet more than expected).
Fields of papers citing papers by M.‐H. Fievet
This network shows the impact of papers produced by M.‐H. Fievet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.‐H. Fievet. The network helps show where M.‐H. Fievet may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M.‐H. Fievet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 53 | |
| 2 | 2014 | 11 | |
| 3 | 2002 | 7 | |
| 4 | 2002 | 11 | |
| 5 | 2001 | 221 | |
| 6 | 2001 | 16 | |
| 7 | [Endovascular treatment of aorto-iliac aneurysms. Made-to-measure endoprotheses increase the feasibility]. | 2000 | 1 |
| 8 | 1999 | 18 | |
| 9 | 1997 | 20 | |
| 10 | [Evolution of the resistance of Streptococcus pneumoniae to erythromycin at the Pitié-Salpêtrière Hospital (1980-1984)]. | 1986 | 2 |
| 11 | [Resistance of Enterobacteria to cefotaxime and lamoxactam at the Pitié-Salpêtrière Hospital in 1982]. | 1984 | 1 |
About M.‐H. Fievet
M.‐H. Fievet is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Microbiology, having authored 11 papers that have together received 361 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Urinary Tract Infections Management (2 papers), Medical Device Sterilization and Disinfection (2 papers), Hepatitis B Virus Studies (2 papers), Hepatitis C virus research (2 papers), HIV/AIDS drug development and treatment (2 papers) and Legionella and Acanthamoeba research (1 paper). The work is most often cited by research in Hepatology (205 citations), Infectious Diseases (149 citations) and Epidemiology (270 citations). M.‐H. Fievet has collaborated with scholars based in France and United States. Frequent co-authors include Carol Brosgart, Christine Katlama, Hamid Namini, Vincent Thibault, Vincent Cálvez, Thierry Poynard, Pamela Vig, John Fry, Y. Benhamou and Marie‐Claude Menet. Their work appears in journals such as The Lancet, Journal of Clinical Microbiology and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.